Show simple item record

dc.contributor.authorDiamandas, Matthew 19:40:10 (GMT) 19:40:10 (GMT)
dc.description.abstractThe non-proteinogenic amino acid Z-dehydrotryptophan can be found in a several naturally occurring peptide. Amongst them are cyclic peptides such as tunicyclin B, the antifungal agents keramamide F and sclerotide A, as well as the antibiotic telomycin and the calcium-dependent antibiotics (CDAs). Despite there being numerous means of accessing simple Z-dehydrotryptophan building blocks, it was only recently that the first synthesis of a Z-dehydrotryptophan peptide containing more than two amino acids was reported. However, the synthetic method reported in this study is labor-intensive and not practical for rapid synthesis of Z-dehydrotryptophan containing peptides. In Chapter 2, a new and highly efficient approach to the synthesis of Z-dehydrotryptophan peptides is initially described. This approach uses Fmoc-β-HOTrp(Boc)(TBS)-OH as a building block, which is readily prepared in high yield and incorporated into peptides using solid-phase Fmoc chemistry. The TBS-protected indolic alcohol eliminates during global deprotection/resin cleavage to give Z-dehydrotryptophan peptides exclusively as the thermodynamically favored Z-isomer. This approach was applied to the solid-phase synthesis of tunicyclin B and sclerotide A which were prepared in 28 % and 24 % overall yields respectively. In Chapter 3, this method was used in the solid-phase synthesis of more challenging targets which included biologically active CDA3a and CDA4a which were prepared in 6 % and 8.5 % overall yields respectively. Furthermore, using a similar solid-phase approach, two CDA analogs, which contain either Trp or Kyn in place of the Z-dehydrotryptophan of CDA4a, were prepared. The antibacterial potencies of CDA3a, CDA4a and these CDA analogs were assessed in order to assemble a preliminary structure activity relation (SAR) study. Finally, early biological studies were conducted on Z-dehydrotryptophan containing CDA4a in order to begin to decipher the CDA’s biological mechanism of action (MoA). Chapter 4 offers general conclusions about the work within this thesis. Furthermore, the chapter presents recommendations for future work to be conducted in a continuation of the findings outlined within this thesis. They include pursuing the synthesis of other, complex Z-dehydrotryptophan containing peptides as well as preparing further CDA analogs in order to conduct a thorough SAR study on this class of compounds.en
dc.publisherUniversity of Waterlooen
dc.titleSolid-Phase Total Synthesis of Dehydrotryptophan-Bearing Cyclic Peptides Tunicyclin B, Sclerotide A, CDA3a and CDA4a using a Protected β-Hydroxytryptophan Building Blocken
dc.typeMaster Thesisen
dc.pendingfalse of Waterlooen
uws-etd.degreeMaster of Scienceen
uws.contributor.advisorTaylor, Scott
uws.contributor.affiliation1Faculty of Scienceen

Files in this item


This item appears in the following Collection(s)

Show simple item record


University of Waterloo Library
200 University Avenue West
Waterloo, Ontario, Canada N2L 3G1
519 888 4883

All items in UWSpace are protected by copyright, with all rights reserved.

DSpace software

Service outages